Z-1436-2014 Class II Terminated

Recalled by Clinical Diagnostic Solutions — Plantation, FL

FDA device recall Z-1436-2014 was initiated by Clinical Diagnostic Solutions on Feb 24, 2013 and is designated Class II. Reason for recall: Elevated MCV results on the 1311-682, 1311-683, and 1311-684 lots. The recall status is terminated (terminated Aug 7, 2014). Affected quantity: 3,540.

Recall details

Product Type
Devices
Report Date
Apr 16, 2014
Initiation Date
Feb 24, 2013
Termination Date
Aug 7, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,540

Product description

Boule Con-Diff Tri-Level Multi-Parameter Assayed Hematology Control, used for in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments.

Reason for recall

Elevated MCV results on the 1311-682, 1311-683, and 1311-684 lots.

Distribution pattern

Worldwide Distribution: USA Nationwide and the countries of IVORY COAST, MEXICO, and Philippines.

Code information

Product Part Number: 501-605 Lot# 1311-682 Exp. 3/26/2014 501-607 Lot# 1311-683, 1311-684 Exp. 3/26/2014 501-608 Lot# 1311-683 Exp. 3/26/2014

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1436-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1436-2014. Report a data issue: hello@regdatalab.com.